Navigation Links
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
Date:11/9/2007

erapeutic categories in the United States. WCRX-F

Forward Looking Statements

This press release contains forward-looking statements, including statements concerning our operations, our economic performance and financial condition, and our business plans and growth strategy and product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words "may," "might," "will," "should," "estimate," "project," "plan," "anticipate," "expect," intend," "outlook," "believe" and other similar expressions are intended to identify forward- looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.

The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial indebtedness; competitive factors in the industry in which we operate; our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we may rely for some of our products or our own manufacturing facility; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific st
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
2. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...
(Date:12/14/2009)... -- The National Organization for Rare Disorders (NORD) today ... lifetime and annual health insurance caps. In a ... distributed widely on Capitol Hill, NORD said the current ... caps to continue for most Americans, contrary to what ... reform and welcomes the promises made by President Obama ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... of Tens of Thousands of New Chronic Hepatitis ... -- Legislation approved by Congress providing for federal ... helping to reduce tens of thousands of new ... United States, the National Viral Hepatitis Roundtable ... included in the FY 2010 Consolidated Appropriations bill ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
Breaking Medicine News(10 mins):Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2
... India's leading vaccine manufacturer Serum Institute of India has manufactured ... vaccines // . ,The vaccine is called Td-Vac ... adolescents and adults. The new vaccine will replace the existing ... ,Td-Vac is priced at Rs 7.50 whereas the TT ...
... health the status of industry. The positive step forward ... provided under the industrial policy. Nursing homes // and ... ,The government move is expected to give a ... state, where half the population lives below the poverty ...
... a test that can detect the Hepatitis C virus using ... of Soroka University Medical Centre // in Israel carried ... functions whose blood must be passed through a machine to ... ,Such patients have a high incidence of Hepatitis C. ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... Health experts in the United States fear that if the deadly ... risk since they are vulnerable // to the H5N1 virus. ... 70 lives in Asia and has appeared in parts of Europe ... slaughtered in an effort to contain the virus. However, experts fear ...
... University of Pennsylvania have obtained valuable insights into various ... // called functional magnetic resonance imaging. It has been ... are active during an event are re-activated when a ... study shows that, as you search for memories of ...
Other Medicine News:Health News:Magnetic Resonance Imaging Can Now Be Used For Mind Reading 2
(Date:12/14/2009)... 14 When staff from a leading ... the difficult to adjust and uncomfortable cubital tunnel ... Products, Inc. (PPI) to develop a superior alternative. ... solutions for nearly five decades, responded with the ... which it announced today. Simple to fit ...
(Date:12/14/2009)... -- Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... sale of Xenogen Biosciences Corporation ("XenBio"), a subsidiary ... Farms, Inc. for approximately $11 million. XenBio ... acquisition of Xenogen Corporation in 2006. Caliper ...
(Date:12/14/2009)... 14 Travelers of Interstate 70 west of ... a bit more colorful when 10 multicolored art forms ... named going home , will eventually include 34 ... graduate student at Herron School of Art and Design, ... Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4New Jersey Leaders Detail Savings for Health Reform 50576 1New Jersey Leaders Detail Savings for Health Reform 50576 2New Jersey Leaders Detail Savings for Health Reform 50576 3New Jersey Leaders Detail Savings for Health Reform 50576 4Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 1Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 2Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 1Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 2
... First 30 Patients Enrolled in Ongoing Study Presented at ... ... Abbott (NYSE: ABT ) today,announced continued positive results from ABSORB, the ... eluting stent platform for the treatment of coronary,artery disease. One-year results from ...
... Dynavax,Technologies Corporation (Nasdaq: DVAX ) today reported ... allergy therapy, to subjects as,part of an environmental exposure ... 300 subjects. Subjects are being screened based on a ... to ragweed allergen in,the chamber is being used to ...
Other Medicine Technology:Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
Medicine Products: